This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Vical, RF Micro: After-Hours Trading

The company noted, however, that sales of components for 3G/4G smartphones rose 16% sequentially in the December quarter, and said it expects "normal seasonality" in the March-ending quarter. It plans to report its full third-quarter results on Jan. 24, and provide further guidance at that time.

The news weighed on other chip makers, such as TriQuint Semiconductor (TQNT), which lost nearly 4% to $4.76 on volume of more than 85,000; and SkyWorks Solutions (SWKS - Get Report), which fell 3% to $16.60 with in excess of 55,000 shares changing hands.

Other stocks making news after the closing bell included Integra LifeSciences (IART - Get Report), which forecast weaker than expected fourth-quarter results and said it's received a warning letter from the Food and Drug Administration related to quality systems and compliance issues at a collagen manufacturing facility in Plainsboro, NJ; ViroPharma (VPHM), which said it sees sales ranging from $600 million to $660 million in 2012 vs. current consensus estimate of $593.2 million; and Ruby Tuesday (RT - Get Report), which gave a below-consensus outlook for its fiscal third quarter ending in February, saying it sees earnings of 12 to 16 cents a share vs. the average analysts' view of 27 cents a share because of increased advertising expenses.

-- Written by Michael Baron in New York.

>To contact the writer of this article, click here: Michael Baron.

>To submit a news tip, send an email to:
Disclosure: TheStreet's editorial policy prohibits staff editors, reporters and analysts from holding positions in any individual stocks.
2 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
VPHM $49.96 -0.02%
RFMD $16.59 -2.07%
TQNT $80.94 -1.47%
IART $70.82 0.00%
RT $4.40 0.00%


Chart of I:DJI
DOW 17,773.64 -57.12 -0.32%
S&P 500 2,065.30 -10.51 -0.51%
NASDAQ 4,775.3580 -29.9330 -0.62%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs